Free Trial

FONAR (FONR) Competitors

FONAR logo
$13.76 +0.22 (+1.59%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONR vs. CVRX, SNWV, TCMD, ZIMV, SMTI, LUNG, RCEL, NVRO, ELMD, and PROF

Should you be buying FONAR stock or one of its competitors? The main competitors of FONAR include CVRx (CVRX), SANUWAVE Health (SNWV), Tactile Systems Technology (TCMD), ZimVie (ZIMV), Sanara MedTech (SMTI), Pulmonx (LUNG), AVITA Medical (RCEL), Nevro (NVRO), Electromed (ELMD), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

FONAR vs.

CVRx (NASDAQ:CVRX) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk.

In the previous week, CVRx and CVRx both had 1 articles in the media. CVRx's average media sentiment score of 1.79 beat FONAR's score of 0.97 indicating that CVRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
FONAR
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CVRx has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500.

75.3% of CVRx shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 18.9% of CVRx shares are held by insiders. Comparatively, 2.2% of FONAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

FONAR received 147 more outperform votes than CVRx when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 73.33% of users gave CVRx an outperform vote.

CompanyUnderperformOutperform
CVRxOutperform Votes
33
73.33%
Underperform Votes
12
26.67%
FONAROutperform Votes
180
74.69%
Underperform Votes
61
25.31%

FONAR has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$51.29M6.27-$59.97M-$2.69-4.59
FONAR$101.57M0.85$10.57M$1.1512.13

FONAR has a net margin of 7.68% compared to CVRx's net margin of -116.91%. FONAR's return on equity of 4.94% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-116.91% -93.06% -51.78%
FONAR 7.68%4.94%3.70%

CVRx presently has a consensus price target of $17.83, suggesting a potential upside of 44.28%. Given CVRx's stronger consensus rating and higher possible upside, equities research analysts plainly believe CVRx is more favorable than FONAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
FONAR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

FONAR beats CVRx on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get FONAR News Delivered to You Automatically

Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FONR vs. The Competition

MetricFONARElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$86.53M$3.27B$5.58B$7.58B
Dividend YieldN/A1.64%5.35%4.04%
P/E Ratio12.1314.8922.9318.20
Price / Sales0.8542.38363.8086.45
Price / Cash4.7844.0938.1634.64
Price / Book0.543.296.534.03
Net Income$10.57M$94.03M$3.21B$247.18M
7 Day Performance-1.34%-3.82%-5.78%-5.56%
1 Month Performance-4.26%-11.68%-0.08%-6.69%
1 Year Performance-29.22%-23.02%6.48%-3.47%

FONAR Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FONR
FONAR
1.4271 of 5 stars
$13.80
+1.9%
N/A-32.5%$85.60M$101.57M12.00480Positive News
CVRX
CVRx
2.1871 of 5 stars
$12.76
+2.2%
$17.83
+39.8%
-24.5%$332.22M$51.29M-4.74160News Coverage
Positive News
Gap Down
SNWV
SANUWAVE Health
N/A$38.71
+2.9%
N/AN/A$330.93M$29.30M-9.9340Gap Down
High Trading Volume
TCMD
Tactile Systems Technology
3.0882 of 5 stars
$13.49
+1.5%
$18.00
+33.4%
-8.6%$318.16M$292.98M19.27980Positive News
Gap Down
ZIMV
ZimVie
2.3214 of 5 stars
$11.49
-1.5%
$23.00
+100.2%
-39.1%$318.01M$449.75M-0.882,700Positive News
SMTI
Sanara MedTech
1.9042 of 5 stars
$35.69
+6.2%
$47.00
+31.7%
-14.6%$311.97M$78.06M-36.0560Gap Down
LUNG
Pulmonx
3.1997 of 5 stars
$7.37
-5.1%
$13.36
+81.2%
-19.9%$293.30M$83.79M-5.12250
RCEL
AVITA Medical
1.6135 of 5 stars
$9.32
+4.0%
$17.25
+85.1%
-48.7%$244.35M$64.25M-3.90130Short Interest ↑
Positive News
Gap Down
NVRO
Nevro
1.052 of 5 stars
$5.79
+0.3%
$6.43
+11.1%
-54.1%$221.98M$408.52M-3.061,215News Coverage
Trading Halted
ELMD
Electromed
1.244 of 5 stars
$24.45
-1.1%
$38.00
+55.4%
+56.3%$209.22M$59.63M32.60160News Coverage
Positive News
Gap Down
PROF
Profound Medical
2.0748 of 5 stars
$6.81
flat
$14.25
+109.3%
-34.7%$204.57M$10.68M-5.08150
Remove Ads

Related Companies and Tools


This page (NASDAQ:FONR) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners